Literature DB >> 18343122

Inhibitors of DNA polymerase beta: activity and mechanism.

Zhijie Gao1, David J Maloney, Larisa M Dedkova, Sidney M Hecht.   

Abstract

Bioassay-guided fractionation of extracts prepared from Couepia polyandra and Edgeworthia gardneri resulted in the isolation of the DNA polymerase beta (pol beta) inhibitors oleanolic acid (1), edgeworin (2), betulinic acid (3), and stigmasterol (4). Study of these pol beta inhibitors revealed that three of them inhibited both the lyase and polymerase activities of DNA polymerase beta, while stigmasterol inhibited only the lyase activity. Further investigation indicated that the four inhibitors had substantially different effects on the DNA-pol beta binary complex that is believed to be an obligatory intermediate in the lyase reaction. It was found that the inhibitors potentiated the inhibitory action of the anticancer drug bleomycin in cultured A549 cells, without any influence on the expression of pol beta in the cells. The results of the unscheduled DNA synthesis assay support the thesis that the potentiation of bleomycin cytotoxicity by DNA pol beta inhibitors was a result of an inhibition of DNA repair synthesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343122     DOI: 10.1016/j.bmc.2008.02.071

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  22 in total

1.  S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde.

Authors:  Victor Chun-Lam Wong; Haley L Cash; Jessica L Morse; Shan Lu; Anatoly Zhitkovich
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

2.  Irreversible inhibition of DNA polymerase beta by an oxidized abasic lesion.

Authors:  Lirui Guan; Marc M Greenberg
Journal:  J Am Chem Soc       Date:  2010-04-14       Impact factor: 15.419

Review 3.  DNA repair dysregulation from cancer driver to therapeutic target.

Authors:  Nicola J Curtin
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

4.  Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.

Authors:  A S Prakasha Gowda; Zucai Suo; Thomas E Spratt
Journal:  Chem Res Toxicol       Date:  2017-01-19       Impact factor: 3.739

5.  DNA damage tolerance: a double-edged sword guarding the genome.

Authors:  Gargi Ghosal; Junjie Chen
Journal:  Transl Cancer Res       Date:  2013       Impact factor: 1.241

Review 6.  Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

Authors:  Ajay Srinivasan; Barry Gold
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

Review 7.  DNA polymerases and cancer.

Authors:  Sabine S Lange; Kei-ichi Takata; Richard D Wood
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 8.  Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation.

Authors:  April M Reed; Melissa L Fishel; Mark R Kelley
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

9.  Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.

Authors:  Andrea Schäfer; Lars Schomacher; Guillermo Barreto; Gabi Döderlein; Christof Niehrs
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

10.  Irreversible inhibition of DNA polymerase β by small-molecule mimics of a DNA lesion.

Authors:  Dumitru Arian; Mohammad Hedayati; Haoming Zhou; Zoe Bilis; Karen Chen; Theodore L DeWeese; Marc M Greenberg
Journal:  J Am Chem Soc       Date:  2014-02-11       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.